COVID-19 therapies investigated

Drug discovery

Benjamin Schwarz of the Rocky Mountain National Labs discusses two therapeutics projects on efficacy against SARS-CoV2 in the macaque model.

17 / 06 / 2020 | Benjamin Schwarz

Many therapeutics approaches are proposed based on their results in cell culture. Benjamin Schwarz of the Rocky Mountain National Labs shares why measuring how much of a drug gets to the site of infection is important when translating these therapeutic approaches to clinical trials and human efficacy.

  • “During normal times, we think of the animal model as this translational kind of gateway between cell culture in vitro experiments and clinical trials.”

    Benjamin Schwarz
Request information